Spectrum of Rift Valley fever virus transmission in Kenya: insights from three distinct regions - PubMed (original) (raw)
. 2007 May;76(5):795-800.
Affiliations
- PMID: 17488893
- PMCID: PMC2367216
Spectrum of Rift Valley fever virus transmission in Kenya: insights from three distinct regions
A Desiree LaBeaud et al. Am J Trop Med Hyg. 2007 May.
Abstract
Rift Valley fever virus (RVFV) is an emerging pathogen that maintains high biodefense priority based on its threat to livestock, its ability to cause human hemorrhagic fever, and its potential for aerosol spread. To define the range of human transmission during inter-epidemic and epidemic periods in Kenya, we tested archived sera from defined populations (N = 1,263) for anti-RVFV IgG by ELISA and plaque reduction neutralization testing. RVFV seroprevalence was 10.8% overall and varied significantly by location, sex, and age. In NW Kenya, high seroprevalence among those born before 1980 indicates that an undetected epidemic may have occurred then. Seroconversion documented in highland areas suggests previously unsuspected inter-epidemic transmission. RVFV seroprevalence is strikingly high in certain Kenyan areas, suggesting endemic transmission patterns that may preclude accurate estimation of regional acute outbreak incidence. The extent of both epidemic and inter-epidemic RVFV transmission in Kenya is greater than previously documented.
Figures
Figure 1
Locations and seroprevalence of RVF study sites in Kenya.
Figure 2
Lokichoggio RVF seropositivity by age group (N = 675) with 95% confidence intervals.
References
- CDC. Viral hemorrhagic fevers: fact sheets. 2002. Rift Valley fever; pp. 1–3.
- Isaacson M. Viral hemorrhagic fever hazards for travelers in Africa. Clin Infect Dis. 2001;33:1707–1712. - PubMed
- WHO. WHO Fact Sheet No 207. 2000. Rift Valley fever; pp. 1–5.
- Laughlin LW, Meegan JM, Strausbaugh LJ. Epidemic Rift Valley fever in Egypt: observations of the spectrum of human illness. Trans R Soc Trop Med Hyg. 1979;73:630–633. - PubMed
- Peters CJ. The role of antivirals in responding to biological threats. In: Knobler SL, Mahmoud AAF, Pray LA, editors. Biological Threats and Terrorism: Assessing the Science and Response Capabilities. Washington: National Academy Press; 2002. pp. 119–130. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- K12 RR023264/RR/NCRR NIH HHS/United States
- U01 AI045473/AI/NIAID NIH HHS/United States
- T32 AI052067-05/AI/NIAID NIH HHS/United States
- T32 AI52067/AI/NIAID NIH HHS/United States
- K12 RR023264-02/RR/NCRR NIH HHS/United States
- 1U01AI45473-S1/AI/NIAID NIH HHS/United States
- U01 AI045473-05S1/AI/NIAID NIH HHS/United States
- T32 AI052067/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources